Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LABU Direxion Daily S&P Biotech Bull 3x Shares

Pre-Mkt 06-29 07:33:47 EDT

276.16

+18.36

+7.12%

盘前278.00

+1.84+0.67%

07:31 EDT

High279.32	Low255.85	Vol768.64K
Open255.85	D1 Closing257.80	Amplitude9.10%
Mkt Cap697.16M	Tradable Cap697.16M	Total Shares2.52M
T/O208.29M	T/O Rate30.45%	Tradable Shares2.52M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":276.16,"timestamp":1782504000000,"preClose":257.8,"halted":0,"volume":768638,"hourTrading":{"tag":"盘前","latestPrice":278,"preClose":276.16,"latestTime":"07:31 EDT","volume":2509,"amount":693834.51943,"timestamp":1782732670112,"change":1.84,"changeRate":0.006663,"amplitude":0.021727},"delay":0,"changeRate":0.07121799844840968,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Pre-Mkt","change":18.36,"latestTime":"06-29 07:33:47 EDT","open":255.85,"high":279.315,"low":255.85,"amount":208291889.56263998,"amplitude":0.09102,"askPrice":280.8,"askSize":200,"bidPrice":276,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782739800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":276.16,"sharesOutstanding":3074486,"nav":277.196,"aum":699777112.81,"dividendRate":0.0037,"bidAskSpread":0.003084,"preHourTrading":{"tag":"盘前","latestPrice":278,"preClose":276.16,"latestTime":"07:31 EDT","volume":2509,"amount":693834.51943,"timestamp":1782732670112,"change":1.84,"changeRate":0.006663,"amplitude":0.021727},"postHourTrading":{"tag":"盘后","latestPrice":276.6,"preClose":276.16,"latestTime":"19:59 EDT","volume":15380,"amount":4234080.2379,"timestamp":1782518383569,"change":0.44,"changeRate":0.001593,"amplitude":0.006395},"volumeRatio":1.1375271270043366,"impliedVol":0.945,"impliedVolPercentile":0.784},"requestUrl":"/m/hq/s/LABU/tweets","defaultTab":"tweets","newsList":[{"id":"2647437658","title":"Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2647437658","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647437658?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":"SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy (“Duchenne” or “DMD”)Fast Track is designed to expedite the development/re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318825/0/en/Satellos-Receives-FDA-Fast-Track-Designation-for-SAT-3247-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4139","BK4588","MSLE","SAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647375106","title":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Biohaven Ltd. (BHVN) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647375106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647375106?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:50","pubTimestamp":1782730248,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Biohaven Ltd. (BHVN) and Praxis Precision ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-biohaven-ltd-bhvn-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-biohaven-ltd-bhvn-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0114720955.EUR","XBI","PRAX","XLV","LU1093756168.USD","BK4585","LU0320765992.SGD","IE0002141913.USD","LU0882574055.USD","LU0128526141.USD","LU0029874061.USD","IE00B4R5TH58.HKD","BK4137","BK4581","BK4588","BK4139","BK4548","ALNY","IE00BFTCPJ56.SGD","HCSG","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1093756325.SGD","LABU","LU0889565916.HKD","BHVN","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647837519","title":"Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide","url":"https://stock-news.laohu8.com/highlight/detail?id=2647837519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647837519?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:50","pubTimestamp":1782730216,"startTime":"0","endTime":"0","summary":"Sandoz (SDZNY) announces that the US Food and Drug Administration, FDA, has accepted for review two Abbreviated New Drug Applications, ANDAs, for g...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sandoz-announces-u-s-fda-accepted-for-review-two-andas-for-tirzepatide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sandoz-announces-u-s-fda-accepted-for-review-two-andas-for-tirzepatide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4007","SDZNY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647737813","title":"Larimar Therapeutics submits first module of rolling BLA for nomlabofusp","url":"https://stock-news.laohu8.com/highlight/detail?id=2647737813","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647737813?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:35","pubTimestamp":1782729306,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics (LRMR) announced it has submitted the first module of its rolling Biologics License Application submission to the FDA for acce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/larimar-therapeutics-submits-first-module-of-rolling-bla-for-nomlabofusp-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/larimar-therapeutics-submits-first-module-of-rolling-bla-for-nomlabofusp-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LRMR","BK4588","BK4585","BK4539","LABU","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647373909","title":"Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2647373909","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647373909?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:30","pubTimestamp":1782729000,"startTime":"0","endTime":"0","summary":"FDA alignment on submission of BLA data package in multi-disciplinary Type B pre-BLA meeting minutes; first module of rolling BLA submitted with remaining modules expected 2H 2026Daily nomlabofusp inc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318791/0/en/Larimar-Therapeutics-Reports-Positive-Open-Label-Data-and-Submission-of-First-Module-of-Rolling-BLA-for-Accelerated-Approval-of-Nomlabofusp-for-Friedreich-s-Ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1169589451.USD","LENZ","LU1169590202.USD","BK4130","BK4535","PK","BK4588","CEO","BK4007","PD","BK4023","FXN","LABU","BK4181","BK4539","FA","BK4585","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378316","title":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Cytokinetics (CYTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647378316?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:40","pubTimestamp":1782726017,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alnylam Pharma (ALNY) and Cytokinetics (CYTK) with b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alnylam-pharma-alny-and-cytokinetics-cytk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0114720955.EUR","LU0029874061.USD","CYTK","BK4137","LABU","BK4548","BK4585","LU0109394709.USD","LU0128526141.USD","BK4139","BK4505","XBI","LU0882574055.USD","HCSG","ALNY","XLV","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","ISBC","688180","BK1191","01093","LU0456827905.SGD","LU1226287529.USD","LU0140636845.USD","AGIX","LU1808992512.USD","XLV","AIPO","ONC","00241","603259","01801","02315","IE00BZ08YS42.EUR","LU1255011170.USD","LU1993786604.SGD","LU1807302812.USD","BK4137","BK1571","06618","LU2039709279.SGD","CHAT","LU1008478684.HKD","BK0239","BK1583","ARTY","LU0315179316.USD","IE00BPRC5H50.USD","86618","600276","BK4585","BK0196","HCSG","09637","BK0028","LU0405327494.USD","LU1251922891.USD","BK1161","LU2328871848.SGD","XBI","LU1303224171.USD","01877","LABU","BK0012","BK0216","BK1502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647351320","title":"Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647351320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647351320?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:30","pubTimestamp":1782725451,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-monopar-therapeutics-inc-mnpr-and-bio-techne-tech-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medtronic-mdt-monopar-therapeutics-inc-mnpr-and-bio-techne-tech-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","LU2089283258.USD","XLV","LU0211326755.USD","TECH","BK4533","LU1023059063.AUD","LU0070302665.USD","MNPR","IE00B64QTZ34.USD","IE000M9KFDE8.USD","BK4137","LU0162691827.USD","IE00BVYPNW00.USD","LU1116320737.USD","LU1506573853.SGD","IE00B3T34201.USD","IE00BQXX3C00.GBP","BK4139","BK4082","LU2089284900.SGD","LU0265550946.USD","LU0122379950.USD","LU0211331839.USD","LU1571399168.USD","LU1989764748.USD","IE00BQXX3D17.EUR","LU2023251221.USD","LABU","BK4581","BK4585","LU0320765489.SGD","XBI","LU0432979614.USD","IE00BFXG1179.USD","IE00B3PB1722.GBP","HCSG","BK4566","LU2112291526.USD","LU0006306889.USD","IE00BDGV0183.EUR","LU1116320901.HKD","BK4121","LU2237957902.USD","LU1057294990.SGD","MDT","IE00B19Z6F94.USD","LU2468319806.SGD","LU1989764664.SGD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322702","title":"Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647322702?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:50","pubTimestamp":1782723018,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Apogee Therapeutics ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-revolution-medicines-rvmd-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-revolution-medicines-rvmd-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0029874061.USD","XLV","LU0889565916.HKD","RVMD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4588","APGE","LABU","IE0002141913.USD","IE00BJT1NW94.SGD","HCSG","BK4581","BK4137","XBI","LU0053671581.USD","LU0128526141.USD","LU0109394709.USD","LU0320765992.SGD","BK4139","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647532403","title":"BrainAurora Wins Xiongan AI Healthcare Competition and Unveils Key Brain Science Breakthroughs","url":"https://stock-news.laohu8.com/highlight/detail?id=2647532403","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647532403?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:39","pubTimestamp":1782722347,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BrainAurora Medical Technology Limited ( ($HK:6681) ). BrainAurora Medical Technology has won the championship ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brainaurora-wins-xiongan-ai-healthcare-competition-and-unveils-key-brain-science-breakthroughs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brainaurora-wins-xiongan-ai-healthcare-competition-and-unveils-key-brain-science-breakthroughs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AGIX","BK4581","ARTY","LABU","XBI","AIPO","LU0029874061.USD","XLV","HCSG","BK4585","LU0128526141.USD","BK4137","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647324828","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324828","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647324828?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:20","pubTimestamp":1782721200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0734 GMT - Ipsen's deal to buy Kartos Therapeutics for up to $1.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","LABU","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647219213","title":"Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647219213","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647219213?lang=en_us&edition=fundamental","pubTime":"2026-06-29 15:11","pubTimestamp":1782717097,"startTime":"0","endTime":"0","summary":"HCA Healthcare, Inc. was removed in late June 2026 from multiple Russell growth indices, including the Russell 1000 Growth and Russell Top 200 Growth, following the earlier announcement that Chief Clinical Officer Dr. Michael Cuffe will step down on August 31, 2026, before transitioning to an advisory role until February 2027.\nThis combination of index exclusion and senior clinical leadership change may influence how investors view HCA’s growth profile, trading activity, and longer-term...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/index-exit-and-c-suite-shift-could-be-a-game-changer-for-hca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/index-exit-and-c-suite-shift-could-be-a-game-changer-for-hca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4185","LU0648001328.SGD","LU0128525929.USD","IE00B775SV38.USD","XLV","LU0882574055.USD","LU0211327993.USD","LU0985489474.SGD","LU0068578508.USD","LU1201861249.SGD","BK4588","IE00B3S45H60.SGD","LU0980610538.SGD","LU1119994496.HKD","LU0868494617.USD","LU0029864427.USD","LU1267930573.SGD","LU1261432733.SGD","LU1267930490.SGD","LU1150488218.USD","BK4504","SG9999014005.SGD","LU1150488135.SGD","HCA","LU2355687059.USD","LU0203347892.USD","LU0433182093.SGD","LU1084165304.USD","SG9999014013.SGD","LABU","BK4581","BK4585","LU1489326972.SGD","XBI","LU0187121727.USD","LU0708994859.HKD","LU0878866978.SGD","LU0211328371.USD","LU0310800379.SGD","LU0203345920.USD","LU0310799852.SGD","SG9999014021.USD","LU0130102774.USD","LU0114720955.EUR","LU2244417387.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139407184","title":"ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=1139407184","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139407184?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:22","pubTimestamp":1782714151,"startTime":"0","endTime":"0","summary":"Shares of ASCLETIS-B (HKEX: 01672) have risen more than 7%. At the time of writing, the stock is up 7.2%, trading at HK$10.42 with a turnover of HK$13.24 million. The company has announced that it...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","VXUS","IND","LABU","BK1515","BK1161","BK1191","BK4104","BK4588","01477","BK4585","BK1574","GIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647340099","title":"Why Viridian Therapeutics (VRDN) Is Up 7.6% After FDA Clears First All‑Stage Thyroid Eye Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2647340099","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647340099?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:21","pubTimestamp":1782703275,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics recently received U.S. FDA approval for Lumvoa (veligrotug-vvze) to treat thyroid eye disease across both active and chronic stages, and the company moved to launch its first commercial product immediately. \nThis approval sets Lumvoa apart as the first therapy cleared for thyroid eye disease regardless of disease stage, potentially expanding treatment options for a broader patient population. \nWe’ll now look at how securing first-in-class, all-stage approval for Lumvoa...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/why-viridian-therapeutics-vrdn-is-up-76-after-fda-clears-fir","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrdn/viridian-therapeutics/news/why-viridian-therapeutics-vrdn-is-up-76-after-fda-clears-fir","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","VRDN","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647341163","title":"Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Insmed (INSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647341163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647341163?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:40","pubTimestamp":1782693612,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on ACADIA Pharmaceuticals (ACAD) and Insmed (INSM). ACADIA Pharmaceu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-pharmaceuticals-acad-and-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-pharmaceuticals-acad-and-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","LU2065171402.SGD","LU0029874061.USD","XBI","LU0128526141.USD","HCSG","LU2065169927.USD","BK4139","ACAD","LU0053671581.USD","BK4588","XLV","BK4585","BK4137","LU0889565916.HKD","LU2065171311.SGD","LABU","LU0109394709.USD","LU0320765992.SGD","INSM","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349003","title":"Algorae Joins Sovereign AI Infrastructure as Healthcare Launch Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349003","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349003?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:43","pubTimestamp":1782690183,"startTime":"0","endTime":"0","summary":"Living Cell Technologies ( ($AU:1AI) ) has issued an announcement. Algorae Pharmaceuticals has been selected as a foundation participant and the he...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/algorae-joins-sovereign-ai-infrastructure-as-healthcare-launch-partner?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/algorae-joins-sovereign-ai-infrastructure-as-healthcare-launch-partner?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","HCSG","XBI","AIPO","LU0128526141.USD","BK4585","LABU","BK4581","LU0029874061.USD","XLV","ARTY","AGIX","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349773","title":"Is DexCom (DXCM) A Bargain On FDA Cleared Stelo Expansion?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349773","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349773?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:12","pubTimestamp":1782688338,"startTime":"0","endTime":"0","summary":"FDA clearance for Stelo expansion puts DexCom (DXCM) back in focus\nDexCom (DXCM) is back on investors’ radar after the FDA cleared expanded use of its Stelo Glucose Biosensor for children aged 2 and older who do not use insulin, along with new international rollout plans.\nSee our latest analysis for DexCom.\nAfter the FDA clearance, DexCom’s recent 1 day share price return of 2.17% contrasts with a softer 7 day share price return of 3.22% and a 30 day share price return of 4.88%. The 90 day...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/is-dexcom-dxcm-a-bargain-on-fda-cleared-stelo-expansion","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/is-dexcom-dxcm-a-bargain-on-fda-cleared-stelo-expansion","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2433249047.HKD","LU0354030438.USD","LU2210150020.SGD","LU1323610961.USD","IE00BMPRXN33.USD","LU2125909247.SGD","LU1923622614.USD","BK4504","LU2125909593.SGD","BK4585","BK4551","LU2210149790.SGD","GB00BDT5M118.USD","LABU","BK4534","BK4082","BK4588","LU2095319765.USD","LU0354030511.USD","IE00BMPRXR70.SGD","LU0266013472.USD","BK4548","DXCM","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647346568","title":"Healius Signs National Agreement Framework With Ramsay Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2647346568","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647346568?lang=en_us&edition=fundamental","pubTime":"2026-06-29 05:45","pubTimestamp":1782683132,"startTime":"0","endTime":"0","summary":"Healius  entered into a national agreement framework with subsidiaries of Ramsay Health Care , effective Wednesday, according to an Australian bourse filing on June 26 after market hours.The framework replaces existing pathology leases and service arrangements with standardized agreements across 13 Ramsay-operated hospitals in New South Wales, Victoria, Queensland and Western Australia, per the filing.The new contracts, with initial terms of two to five years, are expected to generate around AU$45 million in annual revenue, subject to stable customer demand and economic conditions, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7113","BK7124","BK4581","LABU","NHLD","BK4588","XBI","BK4585","XLV","BK7501","RHC.AU","HLS.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647345295","title":"Vital Healthcare Manager’s Stake in Trust Falls as Control Rights Narrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2647345295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647345295?lang=en_us&edition=fundamental","pubTime":"2026-06-29 04:47","pubTimestamp":1782679635,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has shared an update. Vital Healthcare Properties Management Limited has disclosed a significant change in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-managers-stake-in-trust-falls-as-control-rights-narrow?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-managers-stake-in-trust-falls-as-control-rights-narrow?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4137","XLV","XBI","BK4581","LU0029874061.USD","BK4585","LU0128526141.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343007","title":"BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343007","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647343007?lang=en_us&edition=fundamental","pubTime":"2026-06-29 04:00","pubTimestamp":1782676800,"startTime":"0","endTime":"0","summary":"- Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation includes new arm span Z-score data showing a statistically sig","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/28/3318616/0/en/BridgeBio-Announces-Publication-in-the-New-England-Journal-of-Medicine-of-Phase-3-PROPEL-3-Trial-of-Oral-Infigratinib-in-Children-Living-with-Achondroplasia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.335},{"period":"1month","weight":0.4847},{"period":"3month","weight":0.9938},{"period":"6month","weight":0.6103},{"period":"1year","weight":3.728},{"period":"ytd","weight":0.7326}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds (\"ETFs\") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (\"GICS\"). The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.013816},{"month":6,"riseRate":0.75,"avgChangeRate":0.151794},{"month":7,"riseRate":0.636364,"avgChangeRate":0.054287},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"Direxion Daily S&P Biotech Bull 3x Shares","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Direxion Daily S&P Biotech Bull 3x Shares(LABU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Direxion Daily S&P Biotech Bull 3x Shares,LABU,Direxion Daily S&P Biotech Bull 3x Shares股票,Direxion Daily S&P Biotech Bull 3x Shares股票老虎,Direxion Daily S&P Biotech Bull 3x Shares股票老虎国际,Direxion Daily S&P Biotech Bull 3x Shares行情,Direxion Daily S&P Biotech Bull 3x Shares股票行情,Direxion Daily S&P Biotech Bull 3x Shares股价,Direxion Daily S&P Biotech Bull 3x Shares股市,Direxion Daily S&P Biotech Bull 3x Shares股票价格,Direxion Daily S&P Biotech Bull 3x Shares股票交易,Direxion Daily S&P Biotech Bull 3x Shares股票购买,Direxion Daily S&P Biotech Bull 3x Shares股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Direxion Daily S&P Biotech Bull 3x Shares(LABU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}